EUVIMEDEUVIMED entdecken
Crossref

Medicare Advantage Is Associated With Higher Mortality After Antibiotic Spacer Placement for Periprosthetic Joint Infection

Nathanael D Heckmann, Julian Wier, Kevin C Liu, Mary K Richardson, Andrew N Vega, Nicholas A Bedard, Daniel J Berry, John J Callaghan, Jay R Lieberman

The Journal of Arthroplasty · 2025

DOI: 10.1016/j.arth.2024.10.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Nathanael D Heckmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Keck Medical Center of the University of Southern California, Los Angeles, California. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Anti-Bacterial Agents, Medicare Part C, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Privatized Medicare Advantage (MA) plans are an alternative to traditional Medicare (TM). We sought to identify differences in 90-day postoperative mortality and nonfatal adverse events between TM and MA patients undergoing stage 1 antibiotic spacer placement for periprosthetic joint infection (PJI) of the hip or knee. METHODS: A nationally representative database was queried from 2015 to 2021 for adult patients undergoing stage 1 antibiotic spacer placement for PJI. Using the International Classification of Disease, 10th Revision, and Current Procedural Terminology codes, as well as hospital charges for antibiotics, patients undergoing stage 1 exchange arthroplasty for PJI were identified. Patients were then grouped into TM and MA cohorts. The primary outcome was the odds of 90-day mortality. Multivariable logistic regressions were conducted to address possible confounding demographic, comorbidity, and hospital characteristics. RESULTS: Of the 40,346 patients undergoing stage 1 spacer placement for PJI, 16,637 (41.2%) had TM coverage and 9,218 (22.8%) had MA coverage. Mortality within 90 days of surgery was higher in the MA cohort (1.4% versus 1.0%, P = 0.004). Multivariable logistic regression demonstrated significantly higher adjusted odds of mortality (adjusted odds ratio = 1.42, 95% confidence interval = 1.11 to 1.81, P = 0.005) in MA patients compared to TM. CONCLUSIONS: Even after accounting for available confounders with our multivariable analyses, patients enrolled in an MA plan were more than 40% more likely to die within 90 days of surgery compared to patients who have TM coverage. Further study is necessary to better understand the underlying cause of this finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsAnti-Bacterial AgentsMedicare Part CArthroplasty, Replacement, HipArthroplasty, Replacement, KneeHumansMaleFemaleAgedUnited StatesMiddle AgedAged, 80 and overRetrospective StudiesDatabases, FactualHip Prosthesis

Stichwörter der Autor:innen

Medicare AdvantageMedicare insuranceantibiotic spacerperiprosthetic joint infectiontotal joint arthroplasty

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Keck Medical Center of the University of Southern California, Los Angeles, California.
  • Department of Orthopaedic Surgery, Mayo Clinic, Rochester, Minnesota.
  • Department of Orthopaedic Surgery, University of Iowa, Iowa City, Iowa.

Zitieren

APA

Heckmann, N. D., Wier, J., Liu, K. C., Richardson, M. K., Vega, A. N., Bedard, N. A., Berry, D. J., Callaghan, J. J., & Lieberman, J. R. (2025). Medicare Advantage Is Associated With Higher Mortality After Antibiotic Spacer Placement for Periprosthetic Joint Infection. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.10.010

Vancouver

Heckmann ND, Wier J, Liu KC, Richardson MK, Vega AN, Bedard NA, et al. Medicare Advantage Is Associated With Higher Mortality After Antibiotic Spacer Placement for Periprosthetic Joint Infection. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2024.10.010

BibTeX
@article{Heckmann2025,
  author = {Heckmann, Nathanael D and Wier, Julian and Liu, Kevin C and Richardson, Mary K and Vega, Andrew N and Bedard, Nicholas A and Berry, Daniel J and Callaghan, John J and Lieberman, Jay R},
  title = {Medicare Advantage Is Associated With Higher Mortality After Antibiotic Spacer Placement for Periprosthetic Joint Infection},
  journal = {The Journal of Arthroplasty},
  year = {2025},
  doi = {10.1016/j.arth.2024.10.010}
}
Kostenlos starten →